Skip to main content

Dental Bone Graft Substitute Market Worth $659 million by 2025 - Growing Demand From Emerging Markets

 


Growth in the dental bone graft substitute market is driven primarily by the increasing prevalence of dental disorders, continuous product commercialization, market availability & product affordability, rising number of geriatric population, and growing public awareness related to preventive care are driving the growth of the dental bone graft substitute market.

According to the Latest Research by MarketsandMarkets “The global dental bone graft substitute market size is projected to reach USD 659 million by 2025 from USD 450 million in 2020, at a CAGR of 7.9% during the forecast period.”

Market Growth Opportunities:

1. Increasing demand from customers and rising inclination toward cosmetic dentistry
2. Low penetration rates for dental implants
3. Growing demand for bone graft substitutes from emerging markets
4. Changing demographics

Market Size Estimation:

The study involved four major activities to estimate the current size of the dental bone graft substitute market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments.

Both top-down and bottom-up approaches were used to estimate and validate the total size of the dental bone graft substitute market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

1. The key players in the industry and markets have been identified through extensive secondary research.

2. The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.

3. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690

By type, synthetic bone graft segment is expected to grow at the highest CAGR during the forecast period

Increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease to get transferred. Because of these benefits synthetic bone graft is the fastest growing type in the dental bone graft substitutes market.

The synthetic bone graft segment is expected to account for the 22.0% share of the global dental bone graft substitutes market in 2019. IngeniOs from Zimmer Biomet Holdings, Inc. (US) and MASTERGRAFT from BioHorizons IPH, Inc. (US) are some commonly used synthetic bone grafts.

Europe is the largest regional market for Dental bone graft substitute

Europe is one of the major revenue-generating regions in the dental bone graft substitute market. The favorable reimbursement & insurance coverage for major procedures and supportive government regulations for product commercialization are the major factors driving the growth of the dental bone graft substitute market in Europe.

Recent Developments:

1. In 2019, Straumann and Modern Dental Group Limited (Hong Kong) entered a joint venture to create distribution company that will serve the dental communities in Hong Kong and Macau; Peak Dental Solutions Hong Kong Ltd

2. In 2018, Dentsply acquired OraMetrix, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care.

3. In 2018, Straumann acquired 30% stake in Botiss biomaterials.

4. In 2017, Straumann acquired 70% stake of its distributor Batigroup for taking over direct distribution of its products in Turkey.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690

Key Players:

Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US), Geistlich Pharm (Switzerland), RTI Surgical (US), BioHorizons, IPH, Inc (US), Dentium (South Korea), LifeSciences Corporation (US), Smith & Nephew (UK), Novabone LLC (US), Botiss biomaterials GmbH (US), Collagen Matrix Inc. (US), Osteogenics Biomedical (US), LifeNet Health (US), Wright Medical (US), and Stryker Corporation (US).

Danaher is one of the leaders in designing, manufacturing, and marketing innovative products and services to professional, medical, industrial, and commercial customers. The company holds a significant share in the global dental bone graft substitute market. To maintain its market position and ensure future growth, the company adopts organic and inorganic growth strategies.


Labels:

Comments

Post a Comment

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...
Post a Comment
Read more

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...
Post a Comment
Read more

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...
Post a Comment
Read more